| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,489,000 | 17,925,000 | 13,824,000 | 18,569,000 | | Cost of Revenue | 18,104,000 | 16,543,000 | 11,628,000 | 16,131,000 | | | Gross Profit | 1,385,000 | 1,382,000 | 2,196,000 | 2,438,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,114,000 | 1,310,000 | 1,311,000 | 906,000 | | Non Recurring | 575,000 |
-
|
-
| 4,069,000 | | Others | 389,000 | 389,000 | 378,000 | 370,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (693,000) | (317,000) | 507,000 | (2,907,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,000 | (24,000) | (1,000) | 79,000 | | Earnings Before Interest And Taxes | (684,000) | (341,000) | 506,000 | (2,828,000) | | Interest Expense | 130,000 | 82,000 | 79,000 | 116,000 | | Income Before Tax | (814,000) | (423,000) | 427,000 | (2,944,000) | | Income Tax Expense | (185,000) | (169,000) | 118,000 | 334,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (629,000) | (254,000) | 309,000 | (3,278,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (629,000) | (254,000) | 309,000 | (3,278,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($629,000) | ($254,000) | $309,000 | ($3,278,000) |
|
0.11% Nasdaq 0.00%
Income Statement
